Страна: Ирландия
Език: английски
Източник: HPRA (Health Products Regulatory Authority)
Oxybutynin hydrochloride
PCO Manufacturing Ltd.
G04BD; G04BD04
Oxybutynin hydrochloride
10 milligram(s)
Prolonged-release tablet
Drugs for urinary frequency and incontinence; oxybutynin
2021-12-17
PACKAGE LEAFLET: INFORMATION FOR THE USER LYRINEL ® XL 10 MG PROLONGED RELEASE TABLETS OXYBUTYNIN HYDROCHLORIDE READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor, pharmacist or nurse. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1. What Lyrinel XL is and what it is used for 2. What you need to know before you take Lyrinel XL 3. How to take Lyrinel XL 4. Possible side effects 5. How to store Lyrinel XL 6. Contents of the pack and other information 1. WHAT LYRINEL XL IS AND WHAT IT IS USED FOR The name of your medicine is Lyrinel XL prolonged release tablets. It is called Lyrinel XL in this leaflet. Lyrinel XL contains a medicine called oxybutynin hydrochloride. This belongs to a group of medicines called ‘anticholinergics’ or ‘antispasmodics’. Lyrinel XL works by relaxing your bladder muscles. It also stops bladder contractions and delays the desire to pass urine (water). Your tablets are made in a 'prolonged release' form. The tablets are coated with a ‘special membrane’, which slowly release the medicine. This membrane may pass through your body unchanged. This does not affect the way the medicine works. Lyrinel XL can be used: • To help adults control when and how often they pass urine • In children 5 years or older to treat: o Loss of control in passing urine (urinary incontinence) o Increased need or urgency to pass urine o Night time bedwetting, when other treatments have not worked. If your symptoms do not improve after 7 days talk to your doctor. You must talk to a doctor if at any time your symptoms worsen. 2. WHAT YOU NEED TO Прочетете целия документ
Health Products Regulatory Authority 17 December 2021 CRN00CPC9 Page 1 of 2 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT LYRINEL XL 10 mg prolonged release tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each prolonged release tablet contains 10 mg oxybutynin hydrochloride Excipient(s) with known effect: Each LYRINEL XL 10 mg prolonged release tablet contains 0.03 mg lactose. 3 PHARMACEUTICAL FORM Prolonged release tablet. _Product imported from Greece_ Round pink coloured tablet, approximately 7.5 mm in diameter, printed with "10 XL" on one side in black ink. 4 CLINICAL PARTICULARS As per PA22612/008/002 5 PHARMACOLOGICAL PROPERTIES As per PA22612/008/002 6 PHARMACEUTICAL PARTICULARS 6.1 LIST OF EXCIPIENTS Butylhydroxytoluene (E321) Cellulose acetate 398-10 Hypromellose 5 cp Polyethylene glycol 3350 Magnesium stearate Polyethylene oxide 200K Polyethylene oxide 2000K Sodium chloride Black iron oxide (E172) Ferric oxide red (E172) Lactose anhydrous Film coat: Ferric oxide red (E172) Hypromellose 3 cp and 6 cp Polyethylene glycol 400 Polysorbate 80 Titanium dioxide (E171) Printing Ink: Black iron oxide (E172) Hypromellose 6 cp Propylene glycol. 6.2 INCOMPATIBILITIES Not applicable. Health Products Regulatory Authority 17 December 2021 CRN00CPC9 Page 2 of 2 6.3 SHELF LIFE The shelf life expiry date of this product is the date shown on the container and outer carton of the product as marketed in the country of origin. 6.4 SPECIAL PRECAUTIONS FOR STORAGE Keep the container tightly closed in order to protect from moisture. Do not store above 25°C. 6.5 NATURE AND CONTENTS OF CONTAINER High density polyethylene bottles with child resistant closure (polypropylene) and desiccant. Pack size 30 tablets. 6.6 SPECIAL PRECAUTIONS FOR DISPOSAL OF A USED MEDICINAL PRODUCT OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCT AND OTHER HANDLING OF THE PRODUCT Do not remove or swallow the sachet of granules in the bottle. This contains desiccant, which keeps the tablets dry. 7 PARALLEL PRODUCT AUTHORISATI Прочетете целия документ